{"id":"NCT01337089","sponsor":"Jazz Pharmaceuticals","briefTitle":"Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain","officialTitle":"A Multicenter, Non-comparative, Open-label Extension Study to Assess the Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01-19","primaryCompletion":"2016-01-27","completion":"2016-01-27","firstPosted":"2011-04-18","resultsPosted":"2018-04-23","lastUpdate":"2023-04-12"},"enrollment":660,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pain","Advanced Cancer"],"interventions":[{"type":"DRUG","name":"Nabiximols","otherNames":["Sativex®"]}],"arms":[{"label":"Non-comparative, open-label Nabiximols","type":"EXPERIMENTAL"}],"summary":"This was a six-month open-label extension (OLE) study to evaluate the safety of long-term nabiximols (Sativex®) therapy when used as an adjunctive treatment in participants with advanced cancer. The study provided continued availability of nabiximols to participants who completed a preceding Phase 3 study and new (de novo) participants.","primaryOutcome":{"measure":"Percent Of Participants With Treatment-emergent Adverse Events","timeFrame":"Baseline, Day 183","effectByArm":[{"arm":"Nabiximols","deltaMin":82.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":128,"countries":["United States","Australia","Belgium","Bulgaria","Czechia","Germany","Hungary","Israel","Italy","Latvia","Lithuania","Mexico","Poland","Puerto Rico","Romania","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":301,"n":660},"commonTop":["Nausea","Vomiting","Dizziness","Asthenia","Decreased Appetite"]}}